Relmada Therapeutics, Inc.
October 10, 2023 - by Joey Ramson
In the latter part of 2022, $RLMD crashed after negative results for their drug REL-1017 in the treatment of depression. The drug failed to show any improvement in depression symptoms compared to the placebo group. Since then $RLMD has been trading pretty quietly between $2.50 and $5.00. About the same range it traded in for the better part of 2 years from late 2016 to 2019. A close above $5 could be a key point for an up move.
